site stats

Dyne therapeutics competitors

WebApr 9, 2024 · Dyne Therapeutics, Inc. Competitors. Emergent BioSolutions. NYSE:EBS US$529.5m. 4D Molecular Therapeutics. NasdaqGS:FDMT US$535.7m. Alector. NasdaqGS:ALEC US$518.1m. ARS Pharmaceuticals. NasdaqGM:SPRY US$549.4m. Price History & Performance. ... Dyne Therapeutics, Inc., a muscle disease company, … WebApr 4, 2024 · Dyne Therapeutics currently has a consensus target price of $25.83, suggesting a potential upside of 133.79%. Given Dyne Therapeutics’ higher possible upside, equities analysts plainly believe ...

DYN : Dyne Therapeutics Inc - MSN Money

WebDyne Therapeutics to Present at Chardan’s 6th Annual Genetic Medicines Conference WALTHAM, Mass., Sept. 27, 2024 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. … WebFind contact information for Dyne Therapeutics. Learn about their Research & Development, Business Services market share, competitors, and Dyne Therapeutics's … high end shampoo for men https://hendersonmail.org

Safety, Tolerability, Pharmacodynamic, Efficacy, and …

WebApr 7, 2024 · Summary Competitors Valuation Apr 7, 2024. ... Dyne Therapeutics Inc is a bio-technology company focused on providing therapeutics for patients with genetically driven diseases. The company is ... WebFeb 9, 2024 · Competitors: Unknown. Dyne Therapeutics Reviews ... Glassdoor gives you an inside look at what it's like to work at Dyne Therapeutics, including salaries, … WebFeb 9, 2024 · Competitors: Unknown. Dyne Therapeutics Reviews ... Glassdoor gives you an inside look at what it's like to work at Dyne Therapeutics, including salaries, reviews, office photos, and more. This is the Dyne Therapeutics company profile. All content is posted anonymously by employees working at Dyne Therapeutics. high end sewing patterns for wedding gowns

Investors & Media Dyne Therapeutics

Category:DYN Stock Forecast, Price & News (Dyne Therapeutics)

Tags:Dyne therapeutics competitors

Dyne therapeutics competitors

Dyne Therapeutics, Inc. (DYN) Key Stats Comparison

WebDec 30, 2024 · Peers & Competitors. Follow $11.59 0.19 (+1.67%) 3:59 PM 12/30/22. ... Dyne Therapeutics, Inc. (DYN) key stats comparison: compare with other stocks by metrics: valuation, growth, profitability ... WebMar 20, 2024 · Dyne Therapeutics is a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically …

Dyne therapeutics competitors

Did you know?

WebApr 6, 2024 · 91,5%. More Financials. Company. Dyne Therapeutics Inc. is a muscle disease company. The Company is focused on advancing therapeutics for patients with genetically driven diseases. It is utilizing its FORCE platform to overcome the limitations of muscle tissue delivery and oligonucleotide therapeutics for muscle diseases. WebApr 4, 2024 · 5 brokerages have issued twelve-month target prices for Dyne Therapeutics' shares. Their DYN share price forecasts range from $18.00 to $34.00. On average, they …

WebMar 23, 2024 · Dyne Therapeutics is a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven diseases. With its proprietary FORCE™ platform, Dyne is developing modern oligonucleotide therapeutics that are designed to overcome limitations in delivery to … WebApr 3, 2024 · “ Dyne’s breakthrough approach brings the power of modern oligo therapeutics and other payloads to patients with serious muscle diseases," said Jason Rhodes, a partner at Atlas Venture and ...

WebMar 30, 2024 · 85.5% of Dyne Therapeutics shares are held by institutional investors. 43.7% of Precigen shares are held by insiders. Comparatively, 42.3% of Dyne … WebOct 2, 2024 · Dyne Therapeutics Competitors. There are no companies similar to Dyne Therapeutics Dyne Therapeutics Related Companies. ... No industry vertical has been recorded for Dyne Therapeutics View All. Dyne Therapeutics Recommended Market Profiles (6) Telemedicine. 10,000 or More employees. 19 companies.

WebFind company research, competitor information, contact details & financial data for Dyne Therapeutics, Inc. of Waltham, MA. Get the latest business insights from Dun & …

WebAug 1, 2024 · Dyne Therapeutics: ClinicalTrials.gov Identifier: NCT05481879 Other Study ID Numbers: DYNE101-DM1-201 2024-000889-18 ( EudraCT Number ) First Posted: August 1, 2024 Key Record Dates: Last Update Posted: April 7, 2024 Last Verified: April 2024 Individual Participant Data (IPD) Sharing Statement: ... high end shoe polishWebApr 11, 2024 · Dyne Therapeutics has a 52-week low of $4.30 and a 52-week high of $15.63. Dyne Therapeutics ( NASDAQ:DYN - Get Rating ) last issued its quarterly earnings data on Thursday, March 2nd. The company reported ($0.74) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.84) by $0.10. how fast is mach chickenWebDyne Therapeutics is a public company that has been in the industry for 6 years. The company currently specializes in the Biotechnology, Biotechnology, Pharmaceuticals areas. The position of the President & CEO is occupied by Joshua Brumm. Its headquarters is located at Waltham, Massachusetts, USA. The number of employees ranges from 25 to … high end shoe brandsWebDyne Therapeutics Inc Working Capital Per Revenue on the trailing twelve month basis from the forth quarter 2024 to forth quarter 2024, Trends and Ranking, Fundamental Ratios - CSIMarket ... Dyne Therapeutics Inc 's Competition Performance; Dyne Therapeutics Inc 's Competitors Results; DYN's Competitors Stock Performance; how fast is mach 8WebDec 30, 2024 · Peers & Competitors. Follow $11.59 0.19 (+1.67%) 3:59 PM 12/30/22. ... Dyne Therapeutics, Inc. (DYN) key stats comparison: compare with other stocks by … how fast is mach threeWebDyne Therapeutics Inc 's competitive profile, comparisons of quarterly results to its competitors, by sales, income, profitability, market share by products and services - … high end shoe cabinetWebDyne Therapeutics has 5 employees at their 1 location and $165 m in total funding,. See insights on Dyne Therapeutics including office locations, competitors, revenue, … high end shoe brands for women